Mental Health Clinics in Bowman, ND Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Able Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 101 N Main St, Bowman, ND 58623 Phone: 701-523-5844 |
Phoenix Therapy Center, Llc Social Worker Medicare: Not Enrolled in Medicare Practice Location: 402 6th Ave Sw, Bowman, ND 58623 Phone: 701-206-0955 |
Phoenix Therapy Center Pllc Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 402 6th Ave Sw, Bowman, ND 58623 Phone: 701-206-0955 |
Dakota Southwestern Wellness, P. L.l.c. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 606 4th St Sw, Bowman, ND 58623 Phone: 701-523-6985 Fax: 701-279-7185 |
News Archive
Exposure to Manga comics promotes fruit intake and healthy snack selection
A recent pilot study in Brooklyn, New York, with minority students found that exposure to Manga comics (Japanese comic art) promoting fruit intake significantly improved healthy snack selection. As snacking accounts for up to 27% of children's daily caloric intake, and childhood obesity has been linked to inadequate intake of fruits and vegetables, the results of this study could have wide-reaching implications.
Ground-breaking discovery could lead to new treatments for diabetes
Why would a bacteria-killing protein be present in an area of the body that is not normally exposed to bacteria, like the pancreas? Researchers at The Ottawa Hospital and the University of Ottawa puzzled over this question for some time, until they eventually discovered that the protein in question was doing something entirely unexpected - it was actually helping the pancreas regenerate and produce insulin.
Patients offered animal-assisted therapy at UCLA Health
At UCLA Health, patients are offered a special kind of therapy that does not involve needles, medicine or high-tech machines.
Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.
Stony Brook University, CadheRx Therapeutics sign licensing agreement for anti-cancer technology
Stony Brook University has entered into a licensing agreement with a startup company, CadheRx Therapeutics, to develop and market an anti-cancer technology discovered by Sabine Brouxhon, MD, Clinical Associate Professor in the Department of Emergency Medicine at Stony Brook University School of Medicine.
› Verified 3 days ago